The report provides a high-level assessment of the development pipeline for new antibiotics, and sets out the Review’s initial proposals for the action needed at a global level to kick-start antibiotic drug discovery efforts.
This includes proposals for new ways of channelling new money into early-stage research relevant to the tackling antimicrobial resistance; and for major global interventions to ensure that drug developers can be sure of a predictable and viable market for new antibiotics which can successfully tackle society’s most acute unmet needs.
To read the report, click here.
To download the press release, click here.